Coronavirus Disease 2019 (COVID-19) Vaccines – Contract Development and Manufacturing Landscape

All the vital news, analysis, and commentary curated by our industry experts.

$4995

Buy Report View Sample

Published: December 31, 2020 Report Code: GDPS0034MAR-ST

Report Overview
Key Players
Table of Contents
Table
Figures

This expert trend report is a comprehensive look at the contract manufacturing landscape surrounding COVID-19 Vaccine in 2020, including analysis of pipeline drugs, clinical trials, CMO activity, Contract Manufacturing Service Agreements, and funding for manufacturing of COVID-19 Vaccines. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.

Scope

This 77-page report gives an important expert quantitative analysis on the COVID-19 contract vaccine manufacturing industry. Findings are based on the industry’s most comprehensive database of the Pharma industry (GlobalData's Pharma Intelligence Center). The 11 tables and 23 figures throughout the report illustrate major points and trends.

Reasons to Buy

What are the pipeline COVID-19 prophylactic vaccines by developer type?

What are the top pipeline COVID-19 prophylactic vaccines analyst consensus sales forecast?

What is the distribution of COVID-19 prophylactic vaccines clinical trials?

What and Where are CMOs vaccine manufacturing facilities?

What are the COVID-19 vaccine contract manufacturing service agreements by Molecule Type?

What are the COVID-19 vaccine contract manufacturing service agreements by Service?

What are the COVID-19 vaccine contract manufacturing service agreements by CMO?

What are the COVID-19 vaccine contract manufacturing service agreements by Sponsor?

3T Biosciences Inc.
7 Hills Pharma LLC
Abnova Corp.
AbVision Inc.
Acibadem University
Adaptive Phage Therapeutics Inc.
Adimmune Corp.
Advanced BioScience Laboratories Inc.
Advent Srl
Aegis Life Inc.
AGC Biologics Inc.
AJ Vaccines A/S
Akers Biosciences Inc.
Akshaya Bio Inc.
Akston Biosciences Corp.
Albany Molecular Research Inc.
Almac Group Ltd.
Altimmune Inc.
AnGes Inc.
Ankara University
AnyGo Technology Co. Ltd.
Applied Biotechnology Institute Inc.
Arcturus Therapeutics Ltd.
Artes Biotechnology GmbH
Aspen Pharmacare Holdings Ltd.
AstraZeneca Plc.
Attwill Medical Solutions
August Pi i Sunyer Biomedical Research Institute
Auravax Therapeutics Inc.
Aurobindo Pharma Ltd.
Avalon GloboCare Corp.
Avid Bioservices Inc.
Axon Neuroscience SE
Baiya Phytopharm Co. Ltd.
Batavia Biosciences BV
Bavarian Nordic A/S
Beijing Minhai Biotechnology Co. Ltd.
Bezmialem Vakif University
Bharat Biotech Ltd.
Biocad
BioCell Corp Ltd.
Biological E Ltd.
BiOMViS Srl
BioNet-Asia Co Ltd.
BioNTech SE
BioSavita Inc.
BioVaxys Technology Corp.
Bogazici University
Boryung Pharmaceutical Co. Ltd.
BriaCell Therapeutics Corp.
Brighton Biotech Inc.
BrightPath Biotherapeutics Co. Ltd.
Butantan Institute
Cadila Healthcare Ltd.
CanSino Biologics Inc.
CanVirex AG
Capricor Therapeutics Inc.
CaroGen Corp.
Catalent Inc.
Catholic University of Leuven
CEBINA GmbH
CEL-SCI Corp.
Centaur Biopharmaceutical Services Inc.
Center for Genetic Engineering and Biotechnology
Centro Nacional de Biotecnologia
Chimeron Bio Corp.
Chongqing Zhifei Biological Products Co. Ltd.
Chula VRC
Chulalongkorn University
City of Hope
Clover Biopharmaceuticals
Cobra Biologics Ltd.
Codagenix Inc.
Codiak BioSciences Inc.
Columbia University
COVAXX
Covid-19 Vaccine Corp. Ltd.
CSL Behring Australia Pty Ltd.
Curevac AG
Cytovance Biologics Inc.
Daiichi Sankyo Biotech Co. Ltd.
Daiichi Sankyo Co. Ltd.
Dalton Pharma Services
DIOSynVax Ltd.
Dyadic International Inc.
Dynavax Technologies Corp.
EastGate Biotech Corp.
Ege University
Eisai Co. Ltd.
Elixirgen Therapeutics LLC
Emergent BioSolutions Inc.
Emergex Vaccines Holding Ltd.
EpicentRx Inc.
EpiVax Inc.
EpiVax Therapeutics
Epygen Biotech Pvt. Ltd.
ERC Belgium SA
Erciyes University
Esperovax Inc.
eTheRNA Immunotherapies NV
Expres2ion Biotechnologies ApS
Federal Research Center for Research and Development of Immunobiological Preparations
Finlay Vaccine Institute
Flow Pharma Inc.
French National Institute of Health and Medical Research
FUDAN University
Fujifilm Diosynth Biotechnologies USA Inc.
FUJIFILM Toyama Chemical Co Ltd.
G+FLAS Life Sciences Inc.
GeneCure LLC
GeneOne Life Science Inc.
Genexine Inc.
Gennova Biopharmaceuticals Ltd.
GeoVax Labs Inc.
German Cancer Research Center
German Center for Infection Research
Glycovax Pharma Inc.
Green Cross Holdings Corp
Greenlight Biosciences Inc.
Greffex Inc.
Grifols SA
Guanhao Biotech Co. Ltd.
Halix BV
Halo-Bio RNAi Therapeutics Inc.
HaloVax
Hanmi Pharmaceuticals Co. Ltd.
Heat Biologics Inc.
Helix Biogen Consult
Helix Nanotechnologies Inc.
Helmholtz Centre for Infection Research
Humane Genomics Inc.
HuVet bio Inc.
iBio Inc.
Icahn School of Medicine at Mount Sinai
Icosavax Inc.
ID Pharma Co. Ltd.
IDT Biologika GmbH
Immodulon Therapeutics Ltd.
Immune Response BioPharma Inc.
Immunetune BV
Immunitor Inc
ImmunityBio Inc.
Immunomic Therapeutics Inc.
Imophoron Ltd.
Imperial College London
IMV Inc.
Indian Immunologicals Ltd.
Indian Institute of Technology Guwahati
Inimmune Corp
Inmunotek SL
InnoMedica Holding AG
Inovio Pharmaceuticals Inc.
Institute for Translational Vaccinology
Institute of Chemistry
Integral Molecular Inc.
IntelliStem Technologies Inc.
International AIDS Vaccine Initiative
iosBio Pharma Ltd.
ISA Pharmaceuticals BV
ISR Immune System Regulation Holding AB
Israel Institute for Biological Research
Izmir Biomedicine and Genome Center
JCR Pharmaceuticals Co. Ltd.
Jiangsu Province Centers for Disease Control and Prevention
Johnson & Johnson
Kangzhong Beijing Biological Technology Co. Ltd.
Kansas State University
Karolinska Institute
Kazakh National Agrarian University
Kazan Federal University
Keio University
Kentucky BioProcessing LLC
Kiromic BioPharma Inc
KM Biologics C.o Ltd.
Krystal Biotech Inc.
Laboratorios Farmaceuticos Rovi SA
LakePharma Inc.
Lancaster University
LG Chem Ltd.
Ligandal Inc.
LineaRx Inc.
LivingMed Biotech
Lomonosov Moscow State University
Lonza Group Ltd.
Mahidol University
Manhattan Biosolutions Inc.
Massachusetts General Hospital
Max Planck Institute of Colloids and Interfaces
MaxiVAX SA
Medicago Inc.
MediciNova Inc.
Medigen Vaccine Biologics Corp
Mediphage Bioceuticals Inc.
Meissa Vaccines Inc.
Merck KGaA
Metaclipse Therapeutics Corp
Middle East Technical University
MigVax Ltd.
Ministry of Education and Science
Moderna Inc.
Mosaic ImmunoEngineering Inc.
Myeloid Therapeutics Inc.
Mymetics Corp.
Mynvax Pvt. Ltd.
N4 Pharma Plc.
Nagasaki University
Nanolek LLC
National Center for Genetic Engineering and Biotechnology
National Institute of Infectious Diseases
National Research Center Egypt
National University of San Martin
Naval Medical Research Center
Navarrabiomed - Miguel Servet Foundation
Neo7logix USA LLC
Neovii Pharmaceuticals AG
Niigata University
Novartis Gene Therapies
Novasep Holding SAS
Novavax Inc.
NuGenerex Immuno-Oncology Inc.
Oakwood Laboratories LLC
Ohio State University
Ology Bioservices Inc.
Olymvax Biopharmaceuticals Inc.
Oncogen Research Center
Oragenics Inc.
Orgenesis Inc.
Osaka University
OSE Immunotherapeutics
Osivax SAS
Oslo University Hospital
Oswaldo Cruz Foundation
Ottawa Hospital Research Institute
Oxford BioMedica Plc.
Oxford Vacmedix UK. Ltd.
Panacea Biotec Ltd.
Par Sterile Products LLC
Patheon NV
PDS Biotechnology Corp.
PDX Pharmaceuticals LLC
Pennsylvania State University
Peruvian Cayetano Heredia University
Phylex BioSciences Inc.
Polymun Scientific Immunbiologische Forschung GmbH
Predictive Oncology Inc.
Prime Vector Technologies GmbH
Providence Therapeutics Inc.
PT Bio Farma
Pure MHC LLC
Quadram Institute Bioscience (UK)
Rational Vaccines Inc.
Recipharm AB
ReiThera Srl
ReNeuron Group Plc.
Rentschler Biopharma SE
Replicate Bioscience Inc.
Richter-Helm BioLogics GmbH & Co. KG
RNAimmune Inc.
Saiba Gmbh
Saint Petersburg State University
Salk Institute for Biological Studies
Sanofi
Scancell Holdings Plc.
Scientific Research Institute for Biological Safety Problems
Seagull BioSolutions Pvt. Ltd.
Selcuk University
Serum Institute of India Ltd.
SGS Life Science Services
Shanghai Bendao Gene Technology Co. Ltd.
Shenzhen Genius Biotech Services Co. Ltd.
Shenzhen Kangtai Biological Products Co. Ltd.
Sinopharm Group Co. Ltd.
Sinovac Biotech Ltd.
SK Bioscience
Soligenix Inc.
Sorrento Therapeutics Inc.
Source: GlobalData Pharmaceutical Intelligence Center Contract Service Provider Database (Accessed November 23
2020) © GlobalData Plc.
Spicona Inc.
SpyBiotech Ltd.
Statens Serum Institut
Stemirna Therapeutics Inc.
Sumagen Co. Ltd.
Svenska Vaccinfabriken Produktion AB
Symbiosis Pharmaceutical Services Ltd.
Symvivo Inc.
Synlogic Inc.
Talem Therapeutics Inc.
Technovalia Pty. Ltd.
TechnoVax Inc.
Tevogen Bio. Inc.
The Institute for Molecular Medicine Inc.
The Institute of Vaccines and Medical Biologicals
The Peter Doherty Institute for Infection and Immunity
The State Research Center of Virology and Biotechnology VECTOR
The Tokyo Metropolitan Institute of Medical Science
Themis Bioscience GmbH
Theralase Technologies Inc.
Therapure Biopharma Inc.
Theravectys SA
Tonix Pharmaceuticals Holding Corp.
Touchlight Genetics Ltd.
Treos Bio Ltd.
Tulane University
UbiVac LLC
Ufovax
UMN Pharma Inc
United Immunity Co. Ltd.
University of Alberta
University of California Los Angeles
University of California San Diego
University of Cincinnati
University of Florida
University of Hong Kong
University of Hyderabad
University of Iowa
University of Montana
University of Pittsburgh School of Medicine
University of Queensland
University of Sao Paulo
University of Saskatchewan
University of Tokyo
University of Virginia
University of Waterloo
University of Wisconsin Madison
Vabiotech
Vaccine Research Institute
Vaccitech Ltd.
Valneva SE
Valo Therapeutics Oy
Vault Pharma Inc.
Vaxart Inc.
Vaxess Technologies Inc
VaxForm LLC
Vaxil Bio Therapeutics Ltd.
Vaximm AG
Vaxine Pty. Ltd.
Vaxsia Biomedical Inc.
Vaxxas Inc.
VBI Vaccines Inc.
Verndari Inc.
Versatope Therapeutics Inc.
VGXI Inc.
Vibalogics GmbH
Viravaxx AG
Virometix AG
Vivaldi Biosciences Inc.
VLP Therapeutics LLC
Waisman Biomanufacturing
Walter Reed Army Institute of Research
Walvax Biotechnology Co. Ltd.
West China Hospital of Sichuan University
Western University
Xiamen Innovax Biotech Co. Ltd.
Yisheng Biopharma Co. Ltd.
Ziphius Therapeutics NV
Zosano Pharma Corp

| About GlobalData

1 Executive Summary

2 Players

3 Technology Briefing

3.1 What is COVID-19?

3.2 COVID-19 Pipeline Vaccine Types and Technology

4 Trends

5 Industry Analysis

5.1 COVID-19 Pipeline Vaccines

5.2 COVID-19 Vaccine Projected Sales

5.3 Contract Manufacturing Capabilities for Vaccines

5.4 COVID-19 Vaccine Contract Service Agreements

5.5 Investors in COVID-19 Vaccine Manufacturing

5.5.1 Governments

5.5.2 Pharma Companies

5.5.3 CMOs

6 Value Chain

7 Companies

8 Appendix

8.1 Methodology

8.2 Bibliography

8.3 Primary Research – Key Opinion Leaders

8.4 Further Reading

9 About the Authors

| Contact Us

Table

Table 1: COVID-19 Vaccine Trends, 2020

Table 2: Highest Development (Phase II–Marketed) COVID-19 Vaccines, 2020

Table 3: Likelihood of Approval for Infectious Disease Vaccines, 2020

Table 4: Promising COVID-19 Vaccines with Fast Track, WARP, ESI and Rolling Submission Status 2020

Table 5: COVID-19 Vaccine Contract Manufacturing Service Agreements, 2020

Table 6: Government and Non-Governmental Organization Funding Announcements, 2020

Table 7: Pharma Funding Events, 2020

Table 8: CMO Funding Events, 2020

Table 9: CMOs with COVID-19 Vaccine Contract Service Agreements

Table 10: Pharma Company Sponsors with COVID-19 Vaccine Pipeline Drugs

Table 11: Further Reading

Figures

Figure 1: Leading Players for COVID-19 Vaccine Manufacturing and their Place on the Value Chain

Figure 2: COVID-19 Virus Life Cycle

Figure 3: Top COVID-19 Vaccine Trends, 2020

Figure 4: COVID-19 Pipeline Vaccines by Highest Phase, 2020

Figure 5: COVID-19 Pipeline Drugs Type by Highest Phase, 2020

Figure 6: Most Active COVID-19 Vaccine Sponsors Across All Stages of Development, 2020

Figure 7: Most Active COVID-19 Vaccine Developers in Phase II–III, 2020

Figure 8: Clinical Trials (Phases I–III) for COVID-19 Prophylactic Vaccines by Site Location, 2020

Figure 9: COVID-19 Prophylactic Vaccine Pipeline by Developer Type, 2020

Figure 10: COVID-19 Prophylactic Vaccine Global Analyst Consensus Sales Forecast ($B)

Figure 11: COVID-19 Prophylactic Vaccines Global Analyst Consensus Sales Forecast

Figure 12: Contract Manufacturing Vaccine API Facilities, 2020

Figure 13: Top CMOs by Contract Vaccine API Manufacturing Facilities, 2020

Figure 14: Geographic Distribution of Contract Vaccine API Facilities, 2020

Figure 15: Outsourcing of Currently Approved US Vaccines, 2020

Figure 16: COVID-19 Vaccine Contract Manufacturing Service Agreements by Molecule Type, 2020

Figure 17: COVID-19 Vaccine Contract Manufacturing Service Agreements by Service, 2020

Figure 18: Top Vaccines by Number of Contract Manufacturing Service Agreements, 2020

Figure 19: Contract Service Agreements by Deal Country, 2020

Figure 20: CMOs by Most COVID-19 Vaccine Contract Service Agreements, 2020

Figure 21: Pharma Sponsors by Most COVID-19 Vaccine Contract Service Agreements, 2020

Figure 22: Contract Manufacturing Service Agreements and Global COVID-19 Deaths in 2020

Figure 23: The Contract Manufacturing Value Chain

Frequently asked questions

Coronavirus Disease 2019 (COVID-19) Vaccines – Contract Development and Manufacturing Landscape standard reports

Currency USD

Single User

$4,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Coronavirus Disease 2019 (COVID-19) Vaccines – Contract Development and Manufacturing Landscape was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

Assess the relevance of the report
Evaluate the quality of the report
Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more reports

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Coronavirus Disease 2019 (COVID-19) Vaccines – Contract Development and Manufacturing Landscape in real time.

Access a live Coronavirus Disease 2019 (COVID-19) Vaccines – Contract Development and Manufacturing Landscape dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type